Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › OpGen Submits Antibiotic Resistance Test to FDA

OpGen Submits Antibiotic Resistance Test to FDA

May 14, 2019
|
staff reporter

NEW YORK (GenomeWeb) — OpGen said today that it has submitted its Acuitas AMR Gene Panel for the detection of antibiotic resistance to the US Food and Drug Administration for 510(k) clearance.

The PCR-based test is designed to detect 47 antibiotic resistance genes in less than three hours from bacterial isolates. It is currently available for research use only.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Molecular Diagnostics

  1. Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

  2. Guardant Health Q4 Revenues Up 25 Percent

  3. Novacyt Obtains CE Mark for Extraction-Free COVID-19 PCR Test

  4. AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

  5. BioMérieux Reports 21 Percent Revenue Growth in Q4

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.